TerminatedPhase 3

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

NCT01303679

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

BACHELOT

Lyon, France